These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16647574)

  • 1. Adhesion receptor expression by CD34+ cells from peripheral blood or bone marrow grafts: correlation with time to engraftment.
    Gold J; Valinski HM; Hanks AN; Ballen KK; Hsieh CC; Becker PS
    Exp Hematol; 2006 May; 34(5):680-7. PubMed ID: 16647574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation.
    Watanabe T; Dave B; Heimann DG; Jackson JD; Kessinger A; Talmadge JE
    Exp Hematol; 1998 Jan; 26(1):10-8. PubMed ID: 9430509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference between expression of adhesion molecules on CD34+ cells from bone marrow and G-CSF-stimulated peripheral blood.
    Kröger N; Zeller W; Hassan HT; Dierlamm J; Zander AR
    Stem Cells; 1998; 16(1):49-53. PubMed ID: 9474747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of cell adhesion molecules by human hematopoietic progenitor cells from bone marrow and mobilized adult peripheral blood.
    Turner ML; McIlwaine K; Anthony RS; Parker AC
    Stem Cells; 1995 May; 13(3):311-6. PubMed ID: 7542116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
    Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.
    Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Wang Y; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34+ cell responsiveness to stromal cell-derived factor-1alpha underlies rate of engraftment after peripheral blood stem cell transplantation.
    Marquez-Curtis LA; Turner AR; Larratt LM; Letcher B; Lee SF; Janowska-Wieczorek A
    Transfusion; 2009 Jan; 49(1):161-9. PubMed ID: 18954402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of thrombopoiesis kinetics by measurement of reticulated platelets and CD34(+) cell subsets in patients with solid tumors following high dose chemotherapy and autologous peripheral blood progenitor cell support.
    Consolini R; Calleri A; Bengala C; Legitimo A; Conte PF
    Haematologica; 2001 Sep; 86(9):959-64. PubMed ID: 11532624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed platelet engraftment in group O patients after autologous progenitor cell transplantation.
    Hoffmann S; Zhou L; Gu Y; Davenport R; Cooling L
    Transfusion; 2005 Jun; 45(6):885-95. PubMed ID: 15934986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number of megakaryocytic progenitors and adhesion molecule expression of stem cells predict platelet engraftment after allogeneic hematopoietic stem cell transplantation.
    Woo KS; Goh RY; Kim SH; Kwon HC; Kim HJ; Lee YH; Han JY
    Cytotherapy; 2007; 9(6):555-61. PubMed ID: 17882720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
    Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
    Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34+/CD41a+ cells best predict platelet recovery after autologous peripheral blood stem cell transplantation.
    Feng R; Shimazaki C; Inaba T; Takahashi R; Hirai H; Kikuta T; Sumikuma T; Yamagata N; Ashihara E; Fujita N; Nakagawa M
    Bone Marrow Transplant; 1998 Jun; 21(12):1217-22. PubMed ID: 9674855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental changes in adhesion molecule expressions in umbilical cord blood CD34 hematopoietic progenitor and stem cells.
    Surbek DV; Steinmann C; Bürk M; Hahn S; Tichelli A; Holzgreve W
    Am J Obstet Gynecol; 2000 Nov; 183(5):1152-7. PubMed ID: 11084557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to achieve a threshold dose of CD34+ CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation.
    Sartor MM; Garvin F; Antonenas V; Bradstock KF; Gottlieb DJ
    Bone Marrow Transplant; 2007 Nov; 40(9):851-7. PubMed ID: 17704793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD34+ cells homing: quantitative expression of adhesion molecules and adhesion of CD34+ cells to endothelial cells exposed to shear stress.
    Gigant C; Latger-Cannard V; Bensoussan D; Fawzi S; Feugier P; Bordigoni P; Stoltz JF
    Biorheology; 2003; 40(1-3):189-95. PubMed ID: 12454404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
    Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
    Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion molecules on peripheral blood-derived CD34+ cells: effects of cryopreservation and short-term ex vivo incubation with serum and cytokines.
    Koenigsmann MP; Koenigsmann M; Notter M; Neuloh M; Mücke C; Thiel E; Berdel WE
    Bone Marrow Transplant; 1998 Dec; 22(11):1077-85. PubMed ID: 9877270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
    Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
    Klaus J; Herrmann D; Breitkreutz I; Hegenbart U; Mazitschek U; Egerer G; Cremer FW; Lowenthal RM; Huesing J; Fruehauf S; Moehler T; Ho AD; Goldschmidt H
    Eur J Haematol; 2007 Jan; 78(1):21-8. PubMed ID: 17042762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.